Business Context and Reporting Period
This Form 6-K filing by Frontline Plc covers the month of December 2025. The report primarily serves to disclose the outcomes of the Company's 2025 Annual General Meeting (AGM) held on December 8, 2025, in Limassol, Cyprus. The filing confirms that audited consolidated financial statements for the year ended December 31, 2024, were presented to shareholders.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references the presentation of audited financial statements for the 2024 fiscal year but does not include the numerical data within this report.
Material Changes and Corporate Actions
- Board Composition: Shareholders re-elected John Fredriksen, James O'Shaughnessy, Ola Lorentzon, Cato Stonex, Ørjan Svanevik, and Dr. Maria Papakokkinou as Directors. Richard C. Prince was elected as a new Director.
- Auditor Appointment: PricewaterhouseCoopers of Limassol, Cyprus, was re-appointed as the Company's auditors.
- Board Remuneration: The AGM approved a total fee cap of USD 600,000 for the Board of Directors for the year ended December 31, 2025.
- Capital Raising Authority: Shareholders approved the exclusion of pre-emption rights for 12 months, allowing the Board to issue up to 377,377,111 ordinary shares or convertible securities at a price not lower than USD 1 per share/security.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies were detailed in this report, other than the standard disclosure that the information is subject to the Norwegian Securities Trading Act.
Investor Verification Checklist
- Verify the full audited financial statements for the year ended December 31, 2024, which were presented at the AGM but not included in this filing.
- Confirm the impact of the new Director, Richard C. Prince, on the Board's strategic direction.
- Monitor the Board's exercise of the newly granted authority to issue up to 377,377,111 shares or convertible securities without pre-emption rights.
- Review the Company's Remuneration Report for 2024, which was approved on an advisory basis.